Silverfin false false 31/05/2024 31/05/2024 01/06/2023 no description of principal activity A Bryant P Dunstan 26/06/2023 D Harris 26/06/2023 C Mitchell 07/11/2024 11367637 2024-05-31 11367637 bus:Director2 2024-05-31 11367637 bus:Director3 2024-05-31 11367637 bus:Director4 2024-05-31 11367637 2023-05-31 11367637 core:CurrentFinancialInstruments 2024-05-31 11367637 core:CurrentFinancialInstruments 2023-05-31 11367637 2023-06-01 2024-05-31 11367637 bus:Micro-entities 2023-06-01 2024-05-31 11367637 bus:FilletedAccounts 2023-06-01 2024-05-31 11367637 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 11367637 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 11367637 bus:Director1 2023-06-01 2024-05-31 11367637 bus:Director2 2023-06-01 2024-05-31 11367637 bus:Director3 2023-06-01 2024-05-31 11367637 bus:Director4 2023-06-01 2024-05-31 11367637 2022-06-01 2023-05-31 iso4217:GBP xbrli:pure

Company No: 11367637 (England and Wales)

CANSENSE LTD

Unaudited Financial Statements
For the financial year ended 31 May 2024
Pages for filing with the registrar

CANSENSE LTD

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 May 2024

Contents

CANSENSE LTD

COMPANY INFORMATION

For the financial year ended 31 May 2024
CANSENSE LTD

COMPANY INFORMATION (continued)

For the financial year ended 31 May 2024
DIRECTORS A Bryant
P Dunstan (Appointed 26 June 2023)
D Harris (Appointed 26 June 2023)
C Mitchell (Resigned 07 November 2024)
REGISTERED OFFICE Institute Of Life Science 2 Swansea University
Singleton Park
Swansea
SA2 8PP
United Kingdom
COMPANY NUMBER 11367637 (England and Wales)
ACCOUNTANT Evelyn Partners LLP
4th Floor Cumberland House
15-17 Cumberland Place
Southampton
Hampshire
SO15 2BG
CANSENSE LTD

BALANCE SHEET

As at 31 May 2024
CANSENSE LTD

BALANCE SHEET (continued)

For the financial year ended 31 May 2024
2024 2023
£ £
Called up share capital not paid - 100
Fixed assets 123,800 149,819
123,800 149,919
Current assets 163,993 248,183
Prepayments and accrued income 100,290 15,947
Creditors: amounts falling due within one year ( 1,482,018) ( 857,121)
Net current liabilities ( 1,217,735) ( 592,991)
Total assets less current liabilities ( 1,093,935) ( 443,072)
Provisions for liabilities ( 30,950) ( 37,455)
Accruals and deferred income ( 155,545) ( 4,250)
Net liabilities ( 1,280,430) ( 484,777)
Capital and reserves ( 1,280,430) ( 484,777)

For the financial year ending 31 May 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Cansense Ltd (registered number: 11367637) were approved and authorised for issue by the Board of Directors on 24 February 2025 and were signed on its behalf by:

A Bryant
Director
CANSENSE LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 May 2024
CANSENSE LTD

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 May 2024

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 11367637). The address of its registered office is Institute Of Life Science 2 Swansea University, Singleton Park, Swansea, SA2 8PP, United Kingdom.

The Company's functional and presentational currency is GBP.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 13 7